Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara A Hendrickson

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Therapeutic Innovation & Regulatory Science|June 20, 2020
A Framework for Safety Evaluation Throughout the Product Development Life-CycleGreg Ball, Tjark Reblin, James Buchanan, et al.
Gastroenterology|May 6, 2003
Enteric flora and lymphocyte-derived cytokines determine expression of heat shock proteins in mouse colonic epithelial cellsKeishi Kojima, Mark W Musch, Hongyu Ren, et al.
American Journal of Clinical Dermatology|January 31, 2018
Safety of Adalimumab Dosed Every Week and Every Other Week: Focus on Patients with Hidradenitis Suppurativa or PsoriasisCaitriona Ryan, Jeffrey M Sobell, Craig L Leonardi, et al.
Therapeutic Innovation & Regulatory Science|March 23, 2021
Aggregate Safety Assessment Planning for the Drug Development Life-CycleBarbara A Hendrickson, William Wang, Greg Ball, et al.
Advances in Therapy|April 30, 2017
RPC4046, A Novel Anti-interleukin-13 Antibody, Blocks IL-13 Binding to IL-13 α1 and α2 Receptors: A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation First-in-Human StudyCatherine S Tripp, Carolyn Cuff, Andrew L Campbell, et al.
Virology|December 27, 2005
Protection against rotavirus shedding after intranasal immunization of mice with a chimeric VP6 protein does not require intestinal IgAMonica M McNeal, Susan C Stone, Mitali Basu, et al.
American Journal of Physiology. Cell Physiology|December 20, 2002
Protective role of HSP72 against Clostridium difficile toxin A-induced intestinal epithelial cell dysfunctionTom S Liu, Mark W Musch, Kazunori Sugi, et al.
Pharmaceutical Medicine|December 16, 2025
Publicly Available Clinical Trial Safety Data: Review and a Call for Standardization and Improved Reporting PracticesBarbara A Hendrickson, Cynthia McShea, Tarek A Hammad, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 24, 2006
Polymeric immunoglobulin receptor in intestinal immune defense against the lumen-dwelling protozoan parasite GiardiaBarbara J Davids, J E Daniel Palm, Michael P Housley, et al.
Lancet (London, England)|May 23, 2021
Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trialKristian Reich, Henrique D Teixeira, Marjolein de Bruin-Weller, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Therapeutic Innovation & Regulatory Science|June 20, 2020
A Framework for Safety Evaluation Throughout the Product Development Life-CycleGreg Ball, Tjark Reblin, James Buchanan, et al.
Gastroenterology|May 6, 2003
Enteric flora and lymphocyte-derived cytokines determine expression of heat shock proteins in mouse colonic epithelial cellsKeishi Kojima, Mark W Musch, Hongyu Ren, et al.
American Journal of Clinical Dermatology|January 31, 2018
Safety of Adalimumab Dosed Every Week and Every Other Week: Focus on Patients with Hidradenitis Suppurativa or PsoriasisCaitriona Ryan, Jeffrey M Sobell, Craig L Leonardi, et al.
Therapeutic Innovation & Regulatory Science|March 23, 2021
Aggregate Safety Assessment Planning for the Drug Development Life-CycleBarbara A Hendrickson, William Wang, Greg Ball, et al.
Advances in Therapy|April 30, 2017
RPC4046, A Novel Anti-interleukin-13 Antibody, Blocks IL-13 Binding to IL-13 α1 and α2 Receptors: A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation First-in-Human StudyCatherine S Tripp, Carolyn Cuff, Andrew L Campbell, et al.
Virology|December 27, 2005
Protection against rotavirus shedding after intranasal immunization of mice with a chimeric VP6 protein does not require intestinal IgAMonica M McNeal, Susan C Stone, Mitali Basu, et al.
American Journal of Physiology. Cell Physiology|December 20, 2002
Protective role of HSP72 against Clostridium difficile toxin A-induced intestinal epithelial cell dysfunctionTom S Liu, Mark W Musch, Kazunori Sugi, et al.
Pharmaceutical Medicine|December 16, 2025
Publicly Available Clinical Trial Safety Data: Review and a Call for Standardization and Improved Reporting PracticesBarbara A Hendrickson, Cynthia McShea, Tarek A Hammad, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 24, 2006
Polymeric immunoglobulin receptor in intestinal immune defense against the lumen-dwelling protozoan parasite GiardiaBarbara J Davids, J E Daniel Palm, Michael P Housley, et al.
Lancet (London, England)|May 23, 2021
Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trialKristian Reich, Henrique D Teixeira, Marjolein de Bruin-Weller, et al.
Pageof 3